On April 29, NAMD sent a letter to leadership of the Senate Finance Committee and the Senate Health, Education, Labor, and Pensions Committee addressing Senators’ efforts to improve the nation’s behavioral health system. In particular, NAMD praised the Committees for their consideration of lifting restrictions on federal Medicaid payments for services provided in Institutions for […]

Continue reading

This memo aims to support Medicaid Directors in reviewing CMS’s final rule implementing mental health parity requirements in Medicaid under the Mental Health Parity and Addiction Equity Act of 2008. The document explores state Medicaid program and MCO roles and responsibilities under the rule, as well as the general parity requirements. It also highlights key […]

Continue reading

NAMD Spring 2016 Federal Policy Update

NAMD staff prepared a memo for Directors outlining key federal regulatory and legislative priorities for the remainder of the year. It provides a snapshot of major priorities for HHS, including completion of the final Medicaid managed care rule, systems work, and value-based purchasing. It also provides an assessment of legislation which is likely to impact […]

Continue reading

NAMD prepared a memo providing a summary of the Center for Medicare and Medicaid Innovation (CMMI)’s recently-announced Comprehensive Primary Care Plus (CPC+) care model. The memo summarizes the model’s goals, its main features, key components for payers to consider in applying to the model, and potential pros and cons for state participation. Read the full […]

Continue reading

NAMD Comments on SAMHSA Privacy Rule

NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on a proposed rule addressing the confidentiality of substance use disorder information (42 CFR Part 2). In the letter, NAMD requests SAMHSA revise the proposed rule to better support care coordination and information exchange to ensure patient safety and positive outcomes. Read […]

Continue reading

NAMD submitted comments to CMS on the final Medicaid covered outpatient drug rule. In the comments, NAMD calls attention to implementation timeline challenges posed by the rule and provides a suggested approach for handling line extension drugs. Read full letter.  

Continue reading

NAMD issued a memo providing Medicaid Directors with an update on CMS scrutiny of state electronic asset verification programs for aged, blind, and disabled Medicaid beneficiaries. The memo also flags key resources available to assist states in implementing their asset verification programs. NAMD Memo AVP Resources 3-31-16

Continue reading

NAMD sent a letter to U.S. Department of Health and Human Services Secretary Sylvia Mathews Burwell to share the findings of a new value-based purchasing (VBP) report. Based on the report’s findings, the letter requests HHS support Medicaid value-based purchasing in three ways: by promoting Medicaid involvement in federal VBP initiatives, including the prospective payment […]

Continue reading

March 24, 2016 – A new NAMD report, released in partnership with Bailit Health Purchasing and with the support of The Commonwealth Fund, provides an overview of Medicaid’s critical work to design and implement value-based purchasing models in the U.S. health care system. Specifically, it explores Medicaid’s path to transform provider payment away from the […]

Continue reading

NAMD responded to a series of questions from the Senate Finance Committee on how to account for value in the pricing and coverage of breakthrough prescription drug therapies. The letter outlines potential policy options for improving the Medicaid Drug Rebate Program and other options to grant states additional tools for managing the impact of these […]

Continue reading